This escalation is due in part to increasing rates of childhood obesity. Until recently, type 2 diabetes was a disease that afflicted only adults. Now a growing number of children are being diagnosed with obesityrelated type 2 diabetes. Also increasing is the incidence of 'metabolic syndrome' -a complex condition linked to obesity that is characterized by a cluster of closely related clinical features, including insulin resistance, dyslipidaemia and hypertension. Metabolic syndrome is associated with an increased risk of cardiovascular disease, which is ultimately responsible for a considerable proportion of diabetic mortality.
There is, therefore, an urgent need for new approaches to address obesity and type 2 diabetes and their associated complications. In particular, understanding the various processes that give rise to the characteristics of metabolic syndrome and its attendant risks -from abnormal regulation of energy metabolism through to dysfunction of molecular mechanisms -will pave the way for the development of new treatment strategies. And, as the reviews in this Insight highlight, it is hoped that a combination of preventative and therapeutic strategies will ultimately reduce the burden of type 2 diabetes on society.
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